PERSIST: Physician’s Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review

BACKGROUND: Chronic dry eye disease often requires long-term therapy. Tear film alterations in the setting of dry eye may include reduced tear volume as well as an increase in inflammatory cytokines and osmolarity. Topical cyclosporine ophthalmic emulsion 0.05% (Restasis(®); Allergan Inc, Irvine, CA...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mah, Francis, Milner, Mark, Yiu, Samuel, Donnenfeld, Eric, Conway, Taryn M, Hollander, David A
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2012
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514052/
https://ncbi.nlm.nih.gov/pubmed/23226002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S30261
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky